Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MJR-35 long-term safety and efficacy in dysmenorrhea
jRCT2080223493Phase 3Completed
- Sponsor
- Mochida Pharmaceutical Co., Ltd.
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of dienogest in dysmenorrhea, sponsored by Mochida Pharmaceutical Co., Ltd. Started Mar 2017; status: completed.
02
Drugs
dienogest
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on jRCT2080223493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223493.